Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release

5′-aminolevulinate synthase (ALAS) catalyzes the first step in heme biosynthesis, generating 5′-aminolevulinate from glycine and succinyl-CoA. Inherited frameshift indel mutations of human erythroid-specific isozyme ALAS2, within a C-terminal (Ct) extension of its catalytic core that is only present...

Full description

Bibliographic Details
Main Authors: Bailey, HJ, Arruda Bezerra, G, Marcero, JR, Padhi, S, Foster, WR, Rembeza, E, Roy, A, Bishop, DF, Desnick, RJ, Bulusu, G, Dailey, HA, Yue, WW
Format: Journal article
Language:English
Published: Springer Nature 2020
_version_ 1797055112010530816
author Bailey, HJ
Arruda Bezerra, G
Marcero, JR
Padhi, S
Foster, WR
Rembeza, E
Roy, A
Bishop, DF
Desnick, RJ
Bulusu, G
Dailey, HA
Yue, WW
author_facet Bailey, HJ
Arruda Bezerra, G
Marcero, JR
Padhi, S
Foster, WR
Rembeza, E
Roy, A
Bishop, DF
Desnick, RJ
Bulusu, G
Dailey, HA
Yue, WW
author_sort Bailey, HJ
collection OXFORD
description 5′-aminolevulinate synthase (ALAS) catalyzes the first step in heme biosynthesis, generating 5′-aminolevulinate from glycine and succinyl-CoA. Inherited frameshift indel mutations of human erythroid-specific isozyme ALAS2, within a C-terminal (Ct) extension of its catalytic core that is only present in higher eukaryotes, lead to gain-of-function X-linked protoporphyria (XLP). Here, we report the human ALAS2 crystal structure, revealing that its Ct-extension folds onto the catalytic core, sits atop the active site, and precludes binding of substrate succinyl-CoA. The Ct-extension is therefore an autoinhibitory element that must re-orient during catalysis, as supported by molecular dynamics simulations. Our data explain how Ct deletions in XLP alleviate autoinhibition and increase enzyme activity. Crystallography-based fragment screening reveals a binding hotspot around the Ct-extension, where fragments interfere with the Ct conformational dynamics and inhibit ALAS2 activity. These fragments represent a starting point to develop ALAS2 inhibitors as substrate reduction therapy for porphyria disorders that accumulate toxic heme intermediates.
first_indexed 2024-03-06T19:06:41Z
format Journal article
id oxford-uuid:1562458e-407a-4797-b557-a1e24f56837d
institution University of Oxford
language English
last_indexed 2024-03-06T19:06:41Z
publishDate 2020
publisher Springer Nature
record_format dspace
spelling oxford-uuid:1562458e-407a-4797-b557-a1e24f56837d2022-03-26T10:25:21ZHuman aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product releaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1562458e-407a-4797-b557-a1e24f56837dEnglishSymplectic ElementsSpringer Nature2020Bailey, HJArruda Bezerra, GMarcero, JRPadhi, SFoster, WRRembeza, ERoy, ABishop, DFDesnick, RJBulusu, GDailey, HAYue, WW5′-aminolevulinate synthase (ALAS) catalyzes the first step in heme biosynthesis, generating 5′-aminolevulinate from glycine and succinyl-CoA. Inherited frameshift indel mutations of human erythroid-specific isozyme ALAS2, within a C-terminal (Ct) extension of its catalytic core that is only present in higher eukaryotes, lead to gain-of-function X-linked protoporphyria (XLP). Here, we report the human ALAS2 crystal structure, revealing that its Ct-extension folds onto the catalytic core, sits atop the active site, and precludes binding of substrate succinyl-CoA. The Ct-extension is therefore an autoinhibitory element that must re-orient during catalysis, as supported by molecular dynamics simulations. Our data explain how Ct deletions in XLP alleviate autoinhibition and increase enzyme activity. Crystallography-based fragment screening reveals a binding hotspot around the Ct-extension, where fragments interfere with the Ct conformational dynamics and inhibit ALAS2 activity. These fragments represent a starting point to develop ALAS2 inhibitors as substrate reduction therapy for porphyria disorders that accumulate toxic heme intermediates.
spellingShingle Bailey, HJ
Arruda Bezerra, G
Marcero, JR
Padhi, S
Foster, WR
Rembeza, E
Roy, A
Bishop, DF
Desnick, RJ
Bulusu, G
Dailey, HA
Yue, WW
Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release
title Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release
title_full Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release
title_fullStr Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release
title_full_unstemmed Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release
title_short Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release
title_sort human aminolevulinate synthase structure reveals a eukaryotic specific autoinhibitory loop regulating substrate binding and product release
work_keys_str_mv AT baileyhj humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT arrudabezerrag humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT marcerojr humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT padhis humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT fosterwr humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT rembezae humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT roya humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT bishopdf humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT desnickrj humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT bulusug humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT daileyha humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease
AT yueww humanaminolevulinatesynthasestructurerevealsaeukaryoticspecificautoinhibitoryloopregulatingsubstratebindingandproductrelease